Paving the way for anti-Abeta active immunotherapy -
Alzinova genomför riktad emission och fullt garanterad företrädesemission | GU Ventures AB
Alzinova Team - Alzinova
Alzinova
Markus Neuding - Executive Vice President - Spotlight Group AB | LinkedIn
16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Symposia | The Journal of Prevention of Alzheimer's Disease
Alzinova Team - Alzinova
Alzinova genomför riktad emission och fullt garanterad företrädesemission | GU Ventures AB
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic | Translational Psychiatry
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial -
Sedermeradagen Stockholm 2016 - LIVE - YouTube
Alzinova AB
Our Story - Alzinova
Analys Alzinova: Unikt alzheimervaccin med miljardpotential - Carlsquare Corporate Finance
Analys Alzinova: Unikt alzheimervaccin med miljardpotential - Carlsquare Corporate Finance
Mobile - Nordic Life Science – the leading Nordic life science news service
Alzinova Team - Alzinova
Alzinova
Alzinova meddelar nya positiva resultat med sitt vaccin mot Alzheimers sjukdom | IT-Halsa.se
Frontiers | Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer's disease: a cross-sectional metabolomic analysis
GU Ventures på LinkedIn: Alzinova: Primär analys bekräftar positiva fas 1b-resultat med ALZ-101 mot…
Alzinova #HemmaHos - YouTube
Analys Spotlight Group, kv1 2021: Höjda prognoser efter mycket starkt kvartal - Carlsquare Corporate Finance
Marknadsmeddelande 51/19 – Alzinova AB byter lista och avnoteras från Spotlight Stock Market efter marknadens stängning den 8 mars 2019 - IPO.se
Alzinova Team - Alzinova
